CCID Consulting (02176) Releases Nomination Committee Terms of Reference

Bulletin Express
2025/11/28

CCID Consulting (02176) has published the Terms of Reference for its Nomination Committee, outlining the committee’s composition, duties, and procedures. The document specifies that the Nomination Committee must comprise at least three members, with the majority serving as independent non-executive directors. The chair of the committee is required to be either the chair of the Board or an independent non-executive director, ensuring impartial oversight of appointments.

The Terms of Reference focus on establishing clear procedures for reviewing and selecting candidates for directorship and senior management positions. They emphasize the importance of evaluating personal qualifications, independence for independent non-executive positions, and alignment with the company’s strategic goals. Candidates for chief executive officer, deputy general manager, chief finance officer, secretary of the Board, and other key roles must be nominated and then reviewed by the Nomination Committee before being approved by the Board.

The committee is also tasked with examining the composition and diversity of the Board, including factors such as professional expertise and industry knowledge. Regular performance evaluations of the Board, along with succession planning for key roles, are part of the committee’s remit. The Terms of Reference further outline administrative requirements, including meeting protocols, voting procedures, confidentiality obligations, and record-keeping of committee discussions and decisions.

Under these guidelines, the Nomination Committee submits its conclusions and recommendations to the Board. Once a resolution is passed, any subsequent formal appointments and shareholder approvals are processed in accordance with legal and regulatory requirements. This structure is intended to strengthen corporate governance and maintain transparency in the leadership appointments of CCID Consulting.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10